Vital Health Podcast

Vital Health Podcast•vitaltransformation.com

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

Last refreshed: July 8th, 2025 at 6:34 AM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

OECD´s Francesca Colombo, At the Centre of the Covid-19 Storm

Francesca Colombo, M.Sc., is Head of the Health Division at the Organisation for Economic Co-operation and Development (OECD). She is responsible for providing internationally comparable data on health systems and applying economic analysis to health policies, as well as advising policy makers and other stakeholders on how to respond to citizen demands for more and better health care. In this capacity, Francesca has also been involved with the OECD’s partnership with the International Consortium...

Jun 10, 2020•35 min

Yannis Natsis, Pricing and Advocacy under Covid-19

Yannis Natsis leads the advocacy for better and affordable medicines at the European Public Health Alliance (EPHA). Before joining EPHA in January 2016, he worked at the European Parliament, the Greek Ministry of Foreign Affairs, the UN and the private sector in Brussels and Athens. In May 2019, Yannis was appointed to the Management Board of the European Medicines Agency (EMA) by EU Member States. He is one of the two patient representatives on the Board with a 3-year mandate starting in June 2...

Jun 03, 2020•45 min

Wilfred Reilly: "There is no empirical evidence for these lockdowns."

Dr Wilfred Reilly is a political muckraker and data-driven contrarian par excellence. He is currently an Associate Professor of Political Science at Kentucky State University, a historically Black college in Frankfort, Kentucky. He holds a PhD in Political Science from Southern Illinois University and a law degree from the University of Illinois. Reilly's research focuses on empirical testing of political claims which are often very influential but rarely well-supported by scientific data. Dr. R...

May 22, 2020•48 min

Robert Madelin - Innovation and Leadership During a Pandemic

Robert Madelin is the Chairman and Chief Strategist at FIPRA International Ltd. Robert is a rare politician with hands-on experience guiding pan-European policy for IT and healthcare. From 2004-2016 he was the Director General for Communications Networks, Content and Technology (CONNECT) and Director General for Health and Consumer Policy (SANCO). Robert Madelin was also a negotiator for both EU and UK international trade and investment, and served in the Cabinet of European Commission Vice-Pres...

May 15, 2020•37 min

Dimitrios Athanasiou, a Duchenne Patient Advocate in the COVID-19 Era

Working at the sharp edge of finance by restructuring companies, Dimitrios Athanasiou was a very successful business consultant and executive with more than 25 years’ experience on international projects. Then, his life changed when his son was diagnosed with Duchenne Muscular Dystrophy. He has since put his business career aside, becoming a fulltime international patient advocate in Duchenne and in rare diseases. In this podcast we discuss the impact of COVID-19 on both the access to regular ca...

May 12, 2020•30 min

Adrian van den Hoven, Providing Europe’s COVID-19 Medicine Arsenal

Adrian van den Hoven, Director General of Medicines for Europe, sits at the center of the industry body tasked with supplying the majority of the medicines required to fight COVID-19 in Europe. With the record high demands for antiseptics, unprecedented challenges to global supply chains, and the current rush to repurpose and test many generic compounds to fight the WuHan Virus, Medicines for Europe sits in the crosshairs of Europe’s COVID-19 public health challenges. Adrian’s members need to su...

Apr 17, 2020•28 min

BIO CEO Jim Greenwood, An Innovation Led Assault on COVID19

Jim Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C., representing over 1,000 biotechnology companies and academic institutions in more than 30 countries worldwide. In this podcast, we discuss how BIO is at the front lines of the battle to find treatments and cures for COVID19, by harnessing the many technological breakthroughs of the last two decades. As well, we discuss the political fallout to the U.S. biopharma sector being caused by high ...

Apr 08, 2020•39 min

Rick Grobbee - Trials@Home & Tribulations with COVID19

One of the world’s leading Epidemiologists, Rick Grobbee has been at the centre multiple ground breaking projects of the Innovative Medicine’s Initiative that have focused on harnessing health data in new and unique ways. IMI’s GetReal, Big Data for Better Outcomes, and Big Data@Heart have all focused on improving research, but now, Rick Grobbee is leading the newly launched Trials@Home, that will move clinical trials from the hospital to the home, fundamentally changing the way clinical researc...

Mar 24, 2020•29 min

Better Science, Better Health: Sarah Garner, Managing Europe’s Innovation for the WHO

Sarah Garner is the Acting Programme Manager of Health Products and Pharmaceuticals of the WHO Euro, and is the former Associate Director for Scientific Policy and Research at the UK’s National Institute for Health and Care Excellence. She is a visionary seeking new approaches to improve innovation, access, and outcomes in healthcare, and has a nuanced view of the financial realities of R&D and the challenges of our national healthcare systems. In this podcast, Sarah discusses the need to su...

Jan 10, 2020•23 min

Biocom’s Joseph Panetta Discusses the Impact of IPI on the California Biotech Ecosystem

California leads the world in biotech productivity and innovation, and Joseph Panetta, President & CEO of Biocom, has been at the center of the growth of the San Diego biotech ecosystem since 1989. In this podcast, we discuss the various international pricing proposals being discussed in Washington DC, and their potential negative impact on the California biopharma ecosystem. Biocom is an association that advocates for 1200 companies, service sector firms, universities and research institute...

Dec 20, 2019•38 min

← Prev

Hosted on Omny Studio

For the best experience, listen in Metacast app for iOS or Android